Doe v. Taro Pharmaceuticals U.S.A., Inc., No. 25-cv-07815-RFL (Northern District of Cal. (N.D. CAL) Nov. 25, 2025)

Case details
Full caption
Jane Doe v. Taro Pharmaceuticals U.S.A., Inc.
Country
United States
Jurisdiction
Federal
Court
Northern District of California (N.D. CAL)
Decided
Nov. 25, 2025
1 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA JANE DOE, Plaintiff, v. TARO PHARMACEUTICALS U.S.A., INC., et al., Defendants. Case No. 25-cv-07815-RFL ORDER TO SHOW CAUSE In her Motion to Strike (Dkt. No. 49), Doe cited the cases Girafa.com, Inc. v. Alexa Internet, Inc., No. C 08-02745, 2009 WL 361464, at *1 (N.D. Cal. Feb. 11, 2009), and Delacruz v. State Bar of Cal., 2021 WL 326974, at *2 (N.D. Cal. Feb. 1, 2021). The Court was unable to locate these cases. While Doe is a pro se litigant and may be unfamiliar with court rules, she is reminded that every party must conduct “an inquiry reasonable under the circumstances” before submitting a motion. Fed. R. Civ. P. 11(b). Use of generative artificial intelligence tools is permitted, but an individual must personally confirm for themselves the accuracy of any research regardless of the source. An occasional typographical error is different from citing nonexistent cases. Therefore, Doe is ORDERED to explain how these cases came to be cited in her brief, by December 12, 2025. Doe will not be subject to sanctions for these citations. IT IS SO ORDERED. Dated: November 25, 2025 RITA F. LIN United States District Judge Case 3:25-cv-07815-RFL Document 61 Filed 11/25/25 Page 1 of 1
ProvenanceKnow exactly where this document came from.Members see the sourcing behind every authority on DocPost — so you can check the record yourself and cite with confidence.Request access